CHOLESTEROL - A RENAL RISK FACTOR IN DIABETIC NEPHROPATHY

被引:132
作者
MULEC, H
JOHNSEN, SA
WIKLUND, O
BJORCK, S
机构
[1] GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT NEPHROL,S-41345 GOTHENBURG,SWEDEN
[2] GOTHENBURG UNIV,SAHLGRENS HOSP,WALLENBERG LAB CARDIOVASC RES,S-41345 GOTHENBURG,SWEDEN
[3] NO ALVSBORGS HOSP,DEPT NEPHROL,ALVSBORGS,SWEDEN
[4] BORAS HOSP,DEPT NEPHROL,BORAS,SWEDEN
关键词
DIABETES; DIABETIC NEPHROPATHY; LIPIDS; CHOLESTEROL; APOLIPOPROTEINS; ANGIOTENSIN-CONVERTING ENZYME INHIBITION;
D O I
10.1016/S0272-6386(12)70186-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In a prospective follow-up of 30 patients with type 1 diabetes and nephropathy, serum cholesterol, triglycerides, apolipoprotein AI and B, and lipoprotein(a) were determined to study their relationship to the rate of decline in glomerular filtration rate. The patients had proteinuria and advanced nephropathy with a mean ± SD glomerular filtration rate of 39 mL/min/1.73 m2. The decline in glomerular filtration rate was determined during 2.5 ± 0.5 years. High serum cholesterol, triglycerides, and apolipoprotein B were correlated to a more rapid deterioration in kidney function. The rate of decline in glomerular filtration rate was 1.0 ± 2.5 mL/min/yr in the 10 patients with the lowest cholesterol level, compared with 4.5 ± 3.2 mL/min/yr in the patients with the highest serum cholesterol (P = 0.015). The combined effect of the measured lipids, blood pressure, type of antihypertensive treatment, protein intake, proteinuria, and hemoglobin A1C on the rate of decline in glomerular filtration rate was assessed by multiple regression analysis. The measured factors together had a high explanatory power for the rate of decline in glomerular filtration rate. In this model, 73% of the variation in decline in glomerular filtration rate was explained by the measured variables (multiple r2 = 0.73). Low cholesterol and treatment with an angiotensin-converting enzyme inhibitor were the strongest predictors of a favorable renal prognosis. This suggests that hypercholesterolemia is an important risk factor for diabetic nephropathy. © 1993, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码:196 / 201
页数:6
相关论文
共 26 条
[1]  
ATTMAN PO, 1990, 17TH C EDTA WIENN, P71
[2]   CONTRASTING EFFECTS OF ENALAPRIL AND METOPROLOL ON PROTEINURIA IN DIABETIC NEPHROPATHY [J].
BJORCK, S ;
MULEC, H ;
JOHNSEN, SA ;
NYBERG, G ;
AURELL, M .
BMJ-BRITISH MEDICAL JOURNAL, 1990, 300 (6729) :904-907
[3]   RENAL PROTECTIVE EFFECT OF ENALAPRIL IN DIABETIC NEPHROPATHY [J].
BJORCK, S ;
MULEC, H ;
JOHNSEN, SA ;
NORDEN, G ;
AURELL, M .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6823) :339-343
[4]  
DIAMOND JR, 1991, KIDNEY INT, V39, pS29
[5]   FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS - ANALOGIES TO ATHEROSCLEROSIS [J].
DIAMOND, JR ;
KARNOVSKY, MJ .
KIDNEY INTERNATIONAL, 1988, 33 (05) :917-924
[6]  
ELNAHAS AM, 1987, 10TH P INT C NEPHR, V2, P2106
[7]   ABNORMALITIES IN PLASMAS CONCENTRATIONS OF LIPOPROTEINS AND FIBRINOGEN IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH INCREASED URINARY ALBUMIN EXCRETION [J].
JENSEN, T ;
STENDER, S ;
DECKERT, T .
DIABETOLOGIA, 1988, 31 (03) :142-145
[8]   PLASMA-LIPID AND COAGULATION-FACTOR CONCENTRATIONS IN INSULIN DEPENDENT DIABETICS WITH MICROALBUMINURIA [J].
JONES, SL ;
CLOSE, CF ;
MATTOCK, MB ;
JARRETT, RJ ;
KEEN, H ;
VIBERTI, GC .
BRITISH MEDICAL JOURNAL, 1989, 298 (6672) :487-490
[9]   SERUM LP(A) LIPOPROTEIN CONCENTRATIONS IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH MICROALBUMINURIA [J].
KAPELRUD, H ;
BANGSTAD, HJ ;
DAHLJORGENSEN, K ;
BERG, K ;
HANSSEN, KF .
BRITISH MEDICAL JOURNAL, 1991, 303 (6804) :675-678
[10]   EFFECTS OF REDUCED RENAL MASS ON TISSUE-LIPIDS AND RENAL INJURY IN HYPERLIPIDEMIC RATS [J].
KASISKE, BL ;
ODONNELL, MP ;
CLEARY, MP ;
KEANE, WF ;
PHILLIPS, F .
KIDNEY INTERNATIONAL, 1989, 35 (01) :40-47